Research Solutions (RSSS) 10-K 19 Sep 19 2019 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Jun. 30, 2019	Sep. 13, 2019	Dec. 31, 2018
Document And Entity Information
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Registrant Name	Research Solutions, Inc.
Entity Central Index Key	0001386301
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 19,317,128
Trading Symbol	RSSS
Entity Common Stock, Shares Outstanding		24,470,255

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Current assets:
Cash and cash equivalents	$ 5,353,090	$ 4,908,180
Accounts receivable, net of allowance of $100,175 and $115,040, respectively	4,493,169	4,251,251
Prepaid expenses and other current assets	323,591	326,887
Prepaid royalties	0	93,336
Total current assets	10,169,850	9,579,654
Other assets:
Property and equipment, net of accumulated depreciation of $789,788 and $749,923, respectively	36,828	59,043
Deposits and other assets	14,406	14,372
Right of use asset, net of accumulated amortization of $270,777 and $155,698, respectively	192,245	307,324
Total assets	10,413,329	9,960,393
Current liabilities:
Accounts payable and accrued expenses	4,862,895	4,686,946
Deferred revenue	2,310,206	1,665,746
Lease liability, current portion	129,187	119,786
Total current liabilities	7,302,288	6,472,478
Long-term liabilities:
Lease liability, long-term portion	79,326	208,513
Total liabilities	7,381,614	6,680,991
Commitments and contingencies
Stockholders' equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 24,375,948 and 24,016,999 shares issued and outstanding, respectively	24,376	24,017
Additional paid-in capital	23,631,481	22,904,691
Accumulated deficit	(20,514,557)	(19,554,599)
Accumulated other comprehensive loss	(109,585)	(94,707)
Total stockholders' equity	3,031,715	3,279,402
Total liabilities and stockholders' equity	$ 10,413,329	$ 9,960,393

Consolidated Balance Sheets _Pa

Consolidated Balance Sheets [Parenthetical] - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Allowance for Doubtful Accounts Receivable, Current	$ 100,175	$ 115,040
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 789,788	$ 749,923
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	24,375,948	24,016,999
Common Stock, Shares, Outstanding	24,375,948	24,016,999
Use Rights [Member]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 270,777	$ 155,698

Consolidated Statements of Oper

Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Revenue:
Total revenue	$ 28,793,922	$ 28,018,441
Cost of revenue:
Total cost of revenue	20,450,461	20,669,116
Gross profit	8,343,461	7,349,325
Operating expenses:
Selling, general and administrative	9,559,608	9,147,064
Depreciation and amortization	38,816	152,397
Total operating expenses	9,598,424	9,299,461
Loss from operations	(1,254,963)	(1,950,136)
Other income (expenses):
Interest expense	0	(4,000)
Other income	107,308	58,179
Total other income	107,308	54,179
Loss from operations before provision for income taxes	(1,147,655)	(1,895,957)
Provision for income taxes	(27,040)	(39,779)
Loss from continuing operations	(1,174,695)	(1,935,736)
Gain from sale of discontinued operations	214,737	256,995
Net loss	(959,958)	(1,678,741)
Other comprehensive loss:
Foreign currency translation	(14,878)	(23,978)
Comprehensive loss	$ (974,836)	$ (1,702,719)
Loss per common share:
Loss per share from continuing operations, basic and diluted	$ (0.05)	$ (0.08)
Income per share from discontinued operations, basic and diluted	0.01	0.01
Net loss per share, basic and diluted	$ (0.04)	$ (0.07)
Weighted average common shares outstanding, basic and diluted	23,815,761	23,473,105
Platforms [Member]
Revenue:
Total revenue	$ 2,809,201	$ 1,819,149
Cost of revenue:
Total cost of revenue	507,375	378,904
Transactions [Member]
Revenue:
Total revenue	25,984,721	26,199,292
Cost of revenue:
Total cost of revenue	$ 19,943,086	$ 20,290,212

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Other Comprehensive Loss [Member]	Total
Balance at Jun. 30, 2017	$ 23,883	$ 22,267,327	$ (17,875,858)	$ (70,729)	$ 4,344,623
Balance (in shares) at Jun. 30, 2017	23,883,145
Fair value of vested stock options	$ 0	451,475	0	0	451,475
Fair value of vested restricted common stock	$ 424	332,105	0	0	332,529
Fair value of vested restricted common stock (in shares)	423,107
Forfeited restricted common stock	$ 214	(214)	0	0	0
Forfeited restricted common stock (in shares)	214,324
Repurchase and retirement of common stock	$ (121)	(152,618)	0	0	$ (152,739)
Repurchase and retirement of common stock (in shares)	(120,900)				(120,900)
Modification cost of stock options	$ 0	6,233	0	0	$ 6,233
Common stock issued upon exercise of stock options	$ 45	(45)	0	0	$ 0
Common stock issued upon exercise of stock options (in shares)	45,971				462,766
Net loss	$ 0	0	(1,678,741)	0	$ (1,678,741)
Foreign currency translation	0	0	0	(23,978)	(23,978)
Balance at Jun. 30, 2018	$ 24,017	22,904,691	(19,554,599)	(94,707)	3,279,402
Balance (in shares) at Jun. 30, 2018	24,016,999
Fair value of vested stock options	$ 0	523,978	0	0	523,978
Fair value of vested restricted common stock	$ 170	303,024	0	0	303,194
Fair value of vested restricted common stock (in shares)	170,245
Repurchase and retirement of common stock	$ (88)	(199,935)	0	0	$ (200,023)
Repurchase and retirement of common stock (in shares)	(88,250)				(88,250)
Common stock issued upon exercise of stock options	$ 238	99,762			$ 100,000
Common stock issued upon exercise of stock options (in shares)	237,954				396,500
Common stock issued upon exercise of warrants	$ 39	(39)	0	0	$ 0
Common stock issued upon exercise of warrants (in shares)	39,000
Net loss	$ 0	0	(959,958)	0	(959,958)
Foreign currency translation	0	0	0	(14,878)	(14,878)
Balance at Jun. 30, 2019	$ 24,376	$ 23,631,481	$ (20,514,557)	$ (109,585)	$ 3,031,715
Balance (in shares) at Jun. 30, 2019	24,375,948

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flow from operating activities:
Net loss	$ (959,958)	$ (1,678,741)
Adjustment to reconcile net loss to net cash used in operating activities of continuing operations:
Gain from sale of discontinued operations	(214,737)	(256,995)
Depreciation and amortization	38,816	152,397
Amortization of lease right	115,079	110,593
Fair value of vested stock options	523,978	451,475
Fair value of vested restricted common stock	303,194	332,529
Modification cost of stock options	0	6,233
Changes in operating assets and liabilities:
Accounts receivable	(241,918)	1,214,048
Prepaid expenses and other current assets	218,033	126,928
Prepaid royalties	93,336	472,946
Deposits and other assets	0	0
Accounts payable and accrued expenses	175,949	(1,756,110)
Deferred revenue	644,460	330,271
Lease liability	(119,786)	(110,888)
Net cash provided by (used in) operating activities	576,446	(605,314)
Cash flow from investing activities:
Purchase of property and equipment	(15,828)	(29,284)
Purchase of intangible assets	0	(57,452)
Net cash used in investing activities	(15,828)	(86,736)
Cash flow from financing activities:
Common stock repurchase and retirement	(200,023)	(152,739)
Proceeds from the exercise of stock options	100,000	0
Net cash used in financing activities	(100,023)	(152,739)
Effect of exchange rate changes	(15,685)	(20,981)
Net increase (decrease) in cash and cash equivalents	444,910	(865,770)
Cash and cash equivalents, beginning of period	4,908,180	5,773,950
Cash and cash equivalents, end of period	5,353,090	4,908,180
Supplemental disclosures of cash flow information:
Cash paid for income taxes	27,040	39,779
Cash paid for interest	$ 0	$ 4,000

Organization, Nature of Busines

Organization, Nature of Business and Basis of Presentation	12 Months Ended
	Jun. 30, 2019
Organization, Nature of Business and Basis of Presentation
Organization, Nature of Business and Basis of Presentation	Note 1. Organization, Nature of Business and Basis of Presentation Organization Research Solutions, Inc. (the “Company,” “Research Solutions,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006, and is a publicly traded holding company with two wholly owned subsidiaries at June 30, 2019: Reprints Desk, Inc., a Delaware corporation and Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico. On June 30, 2017, we sold the intangible assets of our Reprints and ePrints business line, but specifically excluding billed accounts receivable and respective liabilities, pursuant to an Asset Purchase Agreement dated June 20, 2017. The aggregate net consideration for the sale is comprised of $450,000 paid on the closing date, and earn-out payments of 45% of gross margin over the 30 month period subsequent to the closing date. We have made a policy election to record the contingent consideration when the consideration is determined to be realizable. Nature of Business We provide two service offerings to our customers: annual licenses that allow customers to access and utilize certain premium features of our cloud based software-as-a-service (“SaaS”) research intelligence platform (“Platforms”) and the transactional sale of published scientific, technical, and medical (“STM”) content managed, sourced and delivered through the Platform (“Transactions”). Platforms and Transactions are packaged as a single solution that enable life science and other research intensive organizations to speed up research and development activities with faster, single sourced access and management of content and data used throughout the intellectual property development lifecycle. Platforms Our cloud-based SaaS research intelligence platform consists of proprietary software and Internet-based interfaces sold to customers for an annual subscription fee. Legacy functionality allows customers to initiate orders, route orders for the lowest cost acquisition, manage transactions, obtain spend and usage reporting, automate authentication, and connect seamlessly to in-house and third-party software systems. Customers can also enhance the information resources they already own or license and collaborate around bibliographic information. Additional functionality has recently been added to our Platform in the form of interactive app-like gadgets. An alternative to manual data filtering, identification and extraction, gadgets are designed to gather, augment, and extract data across a variety of formats, including bibliographic citations, tables of contents, RSS feeds, PDF files, XML feeds, and web content. We are rapidly developing new gadgets in order to build an ecosystem of gadgets. Together, these gadgets will provide researchers with an “all in one” toolkit, delivering efficiencies in core research workflows and knowledge creation processes. Our Platform is deployed as a single, multi-tenant system across our entire customer base. Customers securely access the Platform through online web interfaces and via web service APIs that enable customers to leverage Platform features and functionality from within in-house and third-party software systems. The Platform can also be configured to satisfy a customer’s individual preferences. We leverage our Platform’s efficiencies in scalability, stability and development costs to fuel rapid innovation and competitive advantage. Transactions Our Platform provides our customers with a single source to the universe of published STM content that includes over 70 million existing STM articles and over one million newly published STM articles each year. STM content is sold to our customers on a transaction basis. Researchers and knowledge workers in life science and other research-intensive organizations generally require single copies of published STM journal articles for use in their research activities. These individuals are our primary users. Our Platform allows customers to find and download digital versions of STM articles that are critical to their research. Customers submit orders for the articles they need which we source and electronically deliver to them generally in under an hour. This service is generally known in the industry as single article delivery or document delivery. We also obtain the necessary permission licenses from the content publisher or other rights holder so that our customer’s use complies with applicable copyright laws. We have arrangements with hundreds of content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Principles of Consolidation The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2019
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded intangibles, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services or acquisitions, and realization of deferred tax assets. Cash and cash equivalents For purposes of the statements of cash flows, the Company defines cash equivalents as all highly liquid debt instruments purchased with an original maturity of three months or less. Fair value of financial instruments Under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures , fair value is defined as the price at which an asset could be exchanged or a liability transferred in a transaction between knowledgeable, willing parties in the principal or most advantageous market for the asset or liability. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or parameters are not available, valuation models are applied. A fair value hierarchy prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs, other than the quoted prices in active markets, are observable either directly or indirectly. Level 3 – Unobservable inputs based on the Company’s assumptions. The Company is required to use observable market data if such data is available without undue cost and effort. The Company has no fair value items required to be disclosed as of June 30, 2019 or 2018 under these requirements. The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values because of the short maturity of these instruments. Allowance for doubtful accounts The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding. The Company established an allowance for doubtful accounts of $100,175 and $115,040 as of June 30, 2019 and 2018, respectively. Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer’s financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required. Cash denominated in Euros with a US Dollar equivalent of $63,933 and $109,585 at June 30, 2019 and 2018, respectively, was held in accounts at financial institutions located in Europe. The Company has no customers that represent 10% of revenue or more for the years ended June 30, 2019 and 2018. The Company has no customers that accounted for greater than 10% of accounts receivable as of June 30, 2019 and 2018. The following table summarizes our content costs from our vendors: Year Ended June 30, 2019 2018 Vendor A 17 % 15 % Vendor B 12 % 12 % Vendor C 10 % 11 % Property and equipment Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives of 3 to 7 years. Leasehold improvements are amortized over the shorter of the useful lives of the related assets, or the lease term. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses on disposals are included in the consolidated statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended June 30, 2019 and 2018, the Company did not recognize any impairments for its property and equipment. Revenue Recognition In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), ("ASC 606"). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. The Company adopted the guidance of ASC 606 on July 1, 2018. The implementation of ASC 606 had no impact on the consolidated financial statements and no cumulative effect adjustment was recognized. Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company derives its revenues from two sources: annual licenses that allow customers to access and utilize certain premium features of our cloud based SaaS research intelligence platform (“Platforms”) and the transactional sale of STM content managed, sourced and delivered through the Platform (“Transactions”). The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: · identify the contract with a customer; · identify the performance obligations in the contract; · determine the transaction price; · allocate the transaction price to performance obligations in the contract; and · recognize revenue as the performance obligation is satisfied. Platforms We charge a subscription fee that allows customers to access and utilize certain premium features of our Platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. We recognize revenue from single article delivery services upon delivery to the customer provided all other revenue recognition criteria have been met. Deferred Revenue Customer deposits and billings or payments received in advance of revenue recognition are recorded as deferred revenue. Cost of Revenue Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service and data providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers. Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the FASB Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates. Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to a loss of $24,500 and a gain of $8,020, for the years ended June 30, 2019 and 2018, respectively. Cash denominated in Euros with a US Dollar equivalent of $63,933 and $109,585 at June 30, 2019 and 2018, respectively, was held in accounts at financial institutions located in Europe. The following table summarizes the exchange rates used: Year Ended June 30, 2019 2018 Period end Euro : US Dollar exchange rate 1.14 1.17 Average period Euro : US Dollar exchange rate 1.14 1.19 Period end Mexican Peso : US Dollar exchange rate 0.05 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05 Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At June 30, 2019 potentially dilutive securities include options to acquire 3,287,335 shares of common stock, warrants to acquire 1,885,000 shares of common stock and unvested restricted common stock of 311,535. At June 30, 2018 potentially dilutive securities include options to acquire 2,991,835 shares of common stock, warrants to acquire 1,985,000 shares of common stock and unvested restricted common stock of 416,619. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period. Basic and diluted net loss per common share is the same for the years ended June 30, 2019 and 2018 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. Income taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Recently Issued Accounting Pronouncements In June 2018, the FASB issued ASU 2018‑07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” The ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). The guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently assessing the effect that the ASU will have on our financial position, results of operations, and disclosures. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 amends certain disclosure requirements pertaining to fair value measurement, and is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of ASU 2018-13 is not expected to have a material impact on the Company’s financial position, results of operations, and cash flows. Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Property and Equipment

Property and Equipment	12 Months Ended
	Jun. 30, 2019
Property and Equipment
Property and Equipment	Note 3. Property and Equipment Property and equipment consists of the following as of June 30, 2019 and 2018: June 30, June 30, 2019 2018 Computer equipment $ 504,652 $ 489,540 Software 282,080 279,817 Furniture and fixtures 39,884 39,609 Total 826,616 808,966 Less accumulated depreciation (789,788) (749,923) Net, Property and equipment $ 36,828 $ 59,043 Depreciation expense for the years ended June 30, 2019 and 2018 was $38,816 and $53,075, respectively.

Line of Credit

Line of Credit	12 Months Ended
	Jun. 30, 2019
Line of Credit
Line of Credit	Note 4 . Line of Credit The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $2,500,000, or 80% of eligible accounts receivable. The line of credit matures on December 31, 2019, and is subject to certain financial and performance covenants with which we were in compliance as of June 30, 2019. Financial covenants include maintaining an adjusted quick ratio of unrestricted cash and net accounts receivable, divided by current liabilities plus debt less deferred revenue of at least 1.15 to 1.0, and maintaining tangible net worth of $1,500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2017, plus 50% of the dollar value of equity issuances after October 1, 2017 and the principal amount of subordinated debt. The line of credit bears interest at the prime rate plus 2.25% for periods in which we maintain an adjusted quick ratio of 1.3 to 1.0 (the “Streamline Period”), and at the prime rate plus 5.25% when a Streamline Period is not in effect. The interest rate on the line of credit was 6.75% as of June 30, 2019. The line of credit is secured by the Company’s consolidated assets. There were no outstanding borrowings under the line as of June 30, 2019 and June 30, 2018, respectively. As of June 30, 2019, there was approximately $2,215,000 of available credit.

Lease Obligations

Lease Obligations	12 Months Ended
	Jun. 30, 2019
Lease Obligations
Lease Obligations	Note 5. Lease Obligations On December 30, 2016, the Company entered into a 48 month non-cancellable lease for its office facilities that will require monthly payments ranging from $10,350 to $11,475 through January 2021. In accounting for the lease, the Company adopted ASU 2016‑02, Leases which requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease initially measured at the present value of the lease payments. The Company classified the lease as an operating lease and determined that the fair value of the lease assets and liability at the inception of the lease was $463,000 using a discount rate of 3.75%. During the twelve months ended June 30, 2019, the Company made payments of $119,786 towards the lease liability. As of June 30, 2019 and 2018, lease liability amounted to $208,513 and $328,299, respectively. ASU 2016‑02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. Rent expense, including real estate taxes, for the years ended June 30, 2019 and 2018 was $144,963 and $142,742, respectively. The right of use asset at June 30, 2018 was $307,324. During the years ended June 30, 2019 and 2018, the Company reflected amortization of right of use asset of $115,079 and $110,593 related to this lease, respectively, resulting in a net asset balance of $192,245 as of June 30, 2019. Future minimum lease payments under the leases are as follows: Years Ending June 30, Amount 2020 $ 135,035 2021 80,356 Total payments 215,391 Less: Amount representing interest 6,878 Present value of net minimum lease payments 208,513 Less: Current portion 129,187 Non-current portion $ 79,326

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Jun. 30, 2019
Stockholders' Equity
Stockholders' Equity	Note 6. Stockholders’ Equity Stock Options In December 2007, we established the 2007 Equity Compensation Plan (the “2007 Plan”) and in November 2017 we established the 2017 Omnibus Incentive Plan (the “2017 Plan”), collectively (the “Plans”). The Plans were approved by our board of directors and stockholders. The purpose of the Plans is to grant stock and options to purchase our common stock, and other incentive awards, to our employees, directors and key consultants. On November 10, 2016, the maximum number of shares of common stock that may be issued pursuant to awards granted under the 2007 Plan increased from 5,000,000 to 7,000,000. On November 21, 2017, the Company’s stockholders approved the adoption of the 2017 Plan (previously adopted by our board of directors on September 14, 2017), which authorized a maximum of 1,874,513 shares of common stock that may be issued pursuant to awards granted under the 2017 Plan. Upon adoption of the 2017 Plan we ceased granting incentive awards under the 2007 Plan and commenced granting incentive awards under the 2017 Plan. The shares of our common stock underlying cancelled and forfeited awards issued under the 2017 Plan may again become available for grant under the 2017 Plan. Cancelled and forfeited awards issued under the 2007 Plan that were cancelled or forfeited prior to November 21, 2017 became available for grant under the 2007 Plan. As of June 30, 2019, there were 537,246 shares available for grant under the 2017 Plan, and no shares were available for grant under the 2007 Plan. All incentive stock award grants prior to the adoption of the 2017 Plan on November 21, 2017 were made under the 2007 Plan, and all incentive stock award grants after the adoption of the 2017 Plan on November 21, 2017 were made under the 2017 Plan. The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Weighted Weighted Weighted Average Average Average Exercise Exercise Exercise Shares Price Shares Price Shares Price Outstanding at July 1, 2017 3,130,310 1.15 2,994,851 1.15 135,459 1.07 Granted 807,000 1.31 750,000 1.30 57,000 1.44 Options vesting — — 74,333 1.07 (74,333) 1.07 Exercised (462,766) 1.19 (462,766) 1.19 — — Forfeited/Cancelled (482,709) 1.31 (471,042) 1.32 (11,667) 1.07 Outstanding at June 30, 2018 2,991,835 1.16 2,885,376 1.15 106,459 1.27 Granted 717,000 2.22 250,000 2.40 467,000 2.12 Options vesting — — 105,042 1.49 (105,042) 1.49 Exercised (396,500) 1.19 (396,500) 1.19 — — Forfeited/Cancelled (25,000) 1.05 (16,667) 1.05 (8,333) 1.05 Outstanding at June 30, 2019 3,287,335 $ 1.38 2,827,251 $ 1.27 460,084 $ 2.09 The following table presents the assumptions used to estimate the fair values based upon a Black-Scholes option pricing model of the stock options granted during the years ended June 30, 2019 and 2018. Years Ended June 30, 2019 2018 Expected dividend yield — % — % Risk-free interest rate 2.82% - 3.00 % 1.45% - 2.88 % Expected life (in years) 5 - 6 2.6 - 6.0 Expected volatility 68% - 69 % 68% - 76 % The weighted average remaining contractual life of all options outstanding as of June 30, 2019 was 6.13 years. The remaining contractual life for options vested and exercisable at June 30, 2018 was 6.39 years. Furthermore, the aggregate intrinsic value of options outstanding as of June 30, 2019 was $4,588,211, and the aggregate intrinsic value of options vested and exercisable at June 30, 2019 was $4,268,743, in each case based on the fair value of the Company’s common stock on June 30, 2019. During the year ended June 30, 2019, the Company granted 717,000 options to employees and directors with a fair value of $881,860. The total fair value of options that vested during the year ended June 30, 2019 was $523,978 and was included in selling, general and administrative expenses in the accompanying statement of operations. As of June 30, 2019, the amount of unvested compensation related to the unvested options was $425,901 which will be recorded as an expense in future periods as the options vest. During the year ended June 30, 2019, the Company issued 92,954 shares of common stock upon the exercise of 221,500 options on a cashless basis and the Company issued 145,000 shares of common stock on the exercise of 175,000 for cash and common stock, resulting in proceeds to the Company of $100,000. During the year ended June 30, 2018, the Company granted 807,000 options to employees and directors with a fair value of $455,040. The total fair value of options that vested during the year ended June 30, 2018 was $451,475 and was included in selling, general and administrative expenses in the accompanying statement of operations. As of June 30, 2018, the amount of unvested compensation related to these options was $73,353 which will be recorded as an expense in future periods as the options vest. During the year ended June 30, 2018, the Company issued 45,971 shares of common stock upon the exercise of 462,766 options on a cashless basis. On September 30, 2017, options originally issued to a former director to purchase an aggregate of 17,600 shares of the Company’s common stock were modified to extend the exercise period from three months to approximately five years. Stock-based compensation cost of $6,233 was recorded during the year ended June 30, 2018 as a result of the modification. Additional information regarding stock options outstanding and exercisable as of June 30, 2019 is as follows: Option Remaining Exercise Options Contractual Options Price Outstanding Life (in years) Exercisable $ 0.59 8,150 3.00 8,150 0.60 5,000 3.00 5,000 0.65 6,150 3.00 6,150 0.70 225,000 6.44 225,000 0.77 59,500 4.26 59,500 0.80 16,000 6.15 16,000 0.90 25,667 4.81 25,667 0.97 6,000 3.00 6,000 1.00 28,249 4.43 28,249 1.02 227,000 1.43 227,000 1.05 422,529 7.11 419,446 1.07 53,898 3.30 53,898 1.09 151,165 6.44 151,165 1.10 105,000 6.01 105,000 1.14 3,674 3.00 3,674 1.15 209,400 5.12 209,400 1.20 352,414 8.08 343,247 1.25 32,000 3.63 32,000 1.30 243,000 2.68 243,000 1.50 195,000 3.38 195,000 1.59 35,000 8.87 14,583 1.75 1,067 3.00 1,067 1.80 134,050 3.89 134,050 1.85 24,000 3.59 24,000 1.95 295,000 9.02 39,583 1.97 1,422 3.00 1,422 2.40 9.38 2.50 9.89 — Total Warrants The following table summarizes warrant activity: Weighted Average Number of Exercise Warrants Price Outstanding, June 30, 2017 1,985,000 $ 1.25 Granted — — Exercised — — Expired/Cancelled — — Outstanding, June 30, 2018 1,985,000 1.25 Granted — — Exercised (100,000) 1.22 Expired/Cancelled — — Outstanding, June 30, 2019 1,885,000 $ 1.25 Exercisable, June 30, 2018 1,985,000 $ 1.25 Exercisable, June 30, 2019 1,885,000 $ 1.25 During the year ended June 30, 2018, the Company issued 39,000 shares of common stock upon the exercise of 100,000 warrants on a cashless basis. The intrinsic value for all warrants outstanding as of June 30, 2019 was $2,887,050, based on the fair value of the Company’s common stock on June 30, 2019. Additional information regarding warrants outstanding and exercisable as of June 30, 2019 is as follows: Remaining Warrant Warrants Contractual Warrants Exercise Price Outstanding Life (in years) Exercisable $ 1.19 100,000 2.48 100,000 1.25 1,835,000 1.97 1,835,000 Total 1,885,000 1,885,000 Restricted Common Stock Prior to July 1, 2017, the Company issued 1,573,197 shares of restricted common stock to employees valued at $1,563,074, of which $1,150,136 had been recognized as an expense. As of June 30, 2017, 513,194 of these shares with a grant date fair value of $412,938 had not yet vested. During the year ended June 30, 2018, the Company issued an additional 423,107 shares of restricted stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate fair value of the stock awards was $467,952 based on the market price of our common stock ranging from $1.02 to $1.59 per share on the date of grant, which will be amortized over the three-year vesting period. During the year ended June 30, 2019, the Company issued an additional 170,245 shares of restricted stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate fair value of the stock awards was $355,417 based on the market price of our common stock ranging from $1.99 to $2.50 per share on the date of grant, which will be amortized over the three-year vesting period. The total fair value of restricted common stock vested during the year ended June 30, 2019 and 2018 was $303,194 and $332,527, respectively, and is included in selling, general and administrative expenses in the accompanying statements of operations. As of June 30, 2019, the amount of unvested compensation related to issuances of restricted common stock was $412,383, which will be recognized as an expense in future periods as the shares vest. When calculating basic net income (loss) per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date. The following table summarizes restricted common stock activity: Weighted Average Number of Grant Date Shares Fair Value Fair Value Non-vested, June 30, 2017 513,194 $ 412,938 $ 0.92 Granted 423,107 467,952 1.11 Vested (305,358) (332,527) 0.91 Forfeited (214,324) (188,203) 1.00 Non-vested, June 30, 2018 416,619 360,160 1.08 Granted 170,245 355,417 2.09 Vested (275,329) (303,194) 1.05 Forfeited — — — Non-vested, June 30, 2019 311,535 $ 412,383 $ 1.66 Common Stock Repurchase and Retirement Effective as of February 8, 2018, the Compensation Committee of our Board of Directors authorized the repurchase, during calendar year 2018 on the last day of each trading window and otherwise in accordance with our insider trading policies, of up to $300,000 of outstanding common stock (at prices no greater than $3.00 per share) from our employees to satisfy their tax obligations in connection with the vesting of stock incentive awards. The actual number of shares repurchased will be determined by applicable employees in their discretion, and will depend on their evaluation of market conditions and other factors. Effective as of November 13,2018, the Compensation Committee of our Board of Directors authorized the repurchase, during calendar year 2019 on the last day of each trading window and otherwise in accordance with our insider trading policies, of up to $300,000 of outstanding common stock (at prices no greater than $3.00 per share) from our employees to satisfy their tax obligations in connection with the vesting of stock incentive awards. The actual number of shares repurchased will be determined by applicable employees in their discretion, and will depend on their evaluation of market conditions and other factors. During the years ended June 30, 2019 and 2018, we repurchased 88,250 and 120,900 shares of our common stock under the repurchase plan at an average price of approximately $2.27 and $1.26 per share, respectively, for an aggregate amount of $200,023 and $152,739, respectively. As of June 30, 2019, $213,255 remains under the current authorization to repurchase our outstanding common stock from our employees. Shares repurchased are retired and deducted from common stock for par value and from additional paid in capital for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares. The following table summarizes repurchases of our common stock on a monthly basis: Total Number of Shares Approximate Dollar Value Total Number Average Purchased as Part of of Shares that May Yet Be of Shares Price Paid Publicly Announced Purchased Under the Period Purchased 1 per Share Plans or Programs Plans or Programs September 2017 34,800 $ 1.14 — — December 2017 52,300 $ 1.21 — — March 2018 19,750 $ 1.29 — — June 2018 14,050 $ 1.73 — — Year ended June 30, 2018 120,900 $ 1.26 — — September 2018 34,200 $ 2.20 — — December 2018 15,800 $ 2.41 — — March 2019 20,500 $ 2.24 — $ 254,080 June 2019 17,750 $ 2.30 — $ 213,255 Year ended June 30, 2019 88,250 $ 2.27 — $ 213,255 1 Consists of shares of common stock purchased from employees to satisfy tax obligations in connection with the vesting of stock incentive awards.

Contingencies and Commitments

Contingencies and Commitments	12 Months Ended
	Jun. 30, 2019
Contingencies and Commitments
Contingencies and Commitments	Note 7. Contingencies and Commitments Legal Proceedings The Company is involved in legal proceedings in the ordinary course of its business. Although management of the Company cannot predict the ultimate outcome of these legal proceedings with certainty, it believes that the ultimate resolution of the Company’s legal proceedings, including any amounts it may be required to pay, will not have a material effect on the Company’s consolidated financial statements.

Income Taxes

Income Taxes	12 Months Ended
	Jun. 30, 2019
Income Taxes
Income Taxes	Note 8. Income Taxes The provision for income taxes consists of the following for the years ended June 30, 2019 and 2018: Years Ended June 30, 2019 2018 Current Federal $ — $ — State 2,088 2,629 Foreign (Mexico) 24,952 37,150 Deferred Federal — — Foreign — — State — — Provision for income tax expense $ 27,040 $ 39,779 During the year ended June 30, 2019, the Company recorded a provision for income tax expense of $27,040 which consisted of $2,088 in state income tax payments and $24,952 in foreign (Mexico) income tax payments. During the year ended June 30, 2018, the Company recorded a provision for income tax expense of $39,779 which consisted of $2,629 in state income tax payments and $37,150 in foreign (Mexico) income tax payments. The reconciliation of the effective income tax rate to the federal statutory rate is as follows: Years Ended June 30, 2019 2018 Federal income tax rate 21.0 % 34.0 % State tax, net of federal benefit (5.0) % (5.0) % Permanent differences 4.8 % 2.8 % Change in valuation allowance (23.6) % (34.1) % Effective income tax rate (2.8) % (2.4) % Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities at June 30, 2019 and 2018 are as follows: June 30, June 30, 2019 2018 Deferred tax assets: Federal net operating loss carryforward $ 2,587,483 $ 2,585,767 State net operating loss carryforward 387,834 387,112 Intangibles amortization 156,196 156,196 Stock based compensation 1,351,437 1,177,731 Other 176,403 165,901 Total deferred tax assets 4,659,353 4,472,707 Deferred tax liability: Fixed asset depreciation 46,299 40,248 Net deferred tax assets 4,705,652 4,512,955 Less valuation allowance (4,705,652) (4,512,955) $ — $ — The Company has provided a valuation allowance on the deferred tax assets at June 30, 2019 and 2018 to reduce such asset to zero, since there is no assurance that the Company will generate future taxable income to utilize such asset. Management will review this valuation allowance requirement periodically and make adjustments as warranted. The net change in the valuation allowance for the year ended June 30, 2019 was an increase of $192,695. At June 30, 2019 and 2018, the Company had federal net operating loss (“NOL”) carryforwards of approximately $12,735,000 and $11,750,000, respectively, and state NOL carryforwards of approximately $6,445,000 and $6,500,000, respectively. Federal NOLs could, if unused, completely expire in 2034. State NOLs, if unused, completely expire in 2039. Effective January 1, 2007, the Company adopted FASB guidelines that address the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. This guidance also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. At the date of adoption, and as of June 30, 2019 and 2018, the Company did not have a liability for unrecognized tax benefits, and no adjustment was required at adoption. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of June 30, 2019 and 2018, the Company has no accrued interest or penalties related to uncertain tax positions. Company is subject to taxation in the United States and various states and Mexico. The Company is subject to United States federal or state income tax examinations by tax authorities for fiscal years after 2015.

Gain from Sale of Discontinued

Gain from Sale of Discontinued Operations (Reprints and ePrints business line)	12 Months Ended
	Jun. 30, 2019
Gain from Sale of Discontinued Operations (Reprints and ePrints business line)
Gain from Sale of Discontinued Operations (Reprints and ePrints business line)	Note 9. Gain from Sale of Discontinued Operations (Reprints and ePrints business line) On June 30, 2017, we sold the intangible assets of our Reprints and ePrints business line, but specifically excluding billed accounts receivable and respective liabilities, pursuant to an Asset Purchase Agreement dated June 20, 2017. The aggregate net consideration for the sale is comprised of $450,000 paid on the closing date, and earn-out payments of 45% of gross margin over the 30 month period subsequent to the closing date. We have made a policy election to record the contingent consideration when the consideration is determined to be realizable, which amounted to $214,737 and $256,995 for the years ended June 30, 2019 and 2018, respectively.

Subsequent Events

Subsequent Events	12 Months Ended
	Jun. 30, 2019
Subsequent Events
Subsequent Events	Note 10. Subsequent Events Stock Options On August 2, 2019, the Company issued 24,307 shares of common stock upon the exercise of 40,000 options on a cashless basis. Restricted Common Stock On August 1, 2019, the Company issued 70,000 shares of restricted stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $192,500 based on the market price of our common stock of $2.75 per share on the date of grant, which will be amortized over the three-year vesting period.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2019
Summary of Significant Accounting Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded intangibles, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services or acquisitions, and realization of deferred tax assets.
Cash and cash equivalents	Cash and cash equivalents For purposes of the statements of cash flows, the Company defines cash equivalents as all highly liquid debt instruments purchased with an original maturity of three months or less.
Fair value of financial instruments	Fair value of financial instruments Under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures , fair value is defined as the price at which an asset could be exchanged or a liability transferred in a transaction between knowledgeable, willing parties in the principal or most advantageous market for the asset or liability. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or parameters are not available, valuation models are applied. A fair value hierarchy prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs, other than the quoted prices in active markets, are observable either directly or indirectly. Level 3 – Unobservable inputs based on the Company’s assumptions. The Company is required to use observable market data if such data is available without undue cost and effort. The Company has no fair value items required to be disclosed as of June 30, 2019 or 2018 under these requirements. The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values because of the short maturity of these instruments.
Allowance for doubtful accounts	Allowance for doubtful accounts The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding. The Company established an allowance for doubtful accounts of $100,175 and $115,040 as of June 30, 2019 and 2018, respectively.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer’s financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required. Cash denominated in Euros with a US Dollar equivalent of $63,933 and $109,585 at June 30, 2019 and 2018, respectively, was held in accounts at financial institutions located in Europe. The Company has no customers that represent 10% of revenue or more for the years ended June 30, 2019 and 2018. The Company has no customers that accounted for greater than 10% of accounts receivable as of June 30, 2019 and 2018. The following table summarizes our content costs from our vendors: Year Ended June 30, 2019 2018 Vendor A 17 % 15 % Vendor B 12 % 12 % Vendor C 10 % 11 %
Property and equipment	Property and equipment Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives of 3 to 7 years. Leasehold improvements are amortized over the shorter of the useful lives of the related assets, or the lease term. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses on disposals are included in the consolidated statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended June 30, 2019 and 2018, the Company did not recognize any impairments for its property and equipment.
Revenue Recognition	Revenue Recognition In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), ("ASC 606"). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. The Company adopted the guidance of ASC 606 on July 1, 2018. The implementation of ASC 606 had no impact on the consolidated financial statements and no cumulative effect adjustment was recognized. Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company derives its revenues from two sources: annual licenses that allow customers to access and utilize certain premium features of our cloud based SaaS research intelligence platform (“Platforms”) and the transactional sale of STM content managed, sourced and delivered through the Platform (“Transactions”). The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: · identify the contract with a customer; · identify the performance obligations in the contract; · determine the transaction price; · allocate the transaction price to performance obligations in the contract; and · recognize revenue as the performance obligation is satisfied. Platforms We charge a subscription fee that allows customers to access and utilize certain premium features of our Platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. We recognize revenue from single article delivery services upon delivery to the customer provided all other revenue recognition criteria have been met.
Deferred Revenue	Deferred Revenue Customer deposits and billings or payments received in advance of revenue recognition are recorded as deferred revenue.
Cost of Revenue	Cost of Revenue Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service and data providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the FASB Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency	Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to a loss of $24,500 and a gain of $8,020, for the years ended June 30, 2019 and 2018, respectively. Cash denominated in Euros with a US Dollar equivalent of $63,933 and $109,585 at June 30, 2019 and 2018, respectively, was held in accounts at financial institutions located in Europe. The following table summarizes the exchange rates used: Year Ended June 30, 2019 2018 Period end Euro : US Dollar exchange rate 1.14 1.17 Average period Euro : US Dollar exchange rate 1.14 1.19 Period end Mexican Peso : US Dollar exchange rate 0.05 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At June 30, 2019 potentially dilutive securities include options to acquire 3,287,335 shares of common stock, warrants to acquire 1,885,000 shares of common stock and unvested restricted common stock of 311,535. At June 30, 2018 potentially dilutive securities include options to acquire 2,991,835 shares of common stock, warrants to acquire 1,985,000 shares of common stock and unvested restricted common stock of 416,619. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period. Basic and diluted net loss per common share is the same for the years ended June 30, 2019 and 2018 because all stock options, warrants, and unvested restricted common stock are anti-dilutive.
Income taxes	Income taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2018, the FASB issued ASU 2018‑07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” The ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). The guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently assessing the effect that the ASU will have on our financial position, results of operations, and disclosures. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 amends certain disclosure requirements pertaining to fair value measurement, and is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of ASU 2018-13 is not expected to have a material impact on the Company’s financial position, results of operations, and cash flows. Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jun. 30, 2019
Summary of Significant Accounting Policies
Schedule of Concentration of Risk	Year Ended June 30, 2019 2018 Vendor A 17 % 15 % Vendor B 12 % 12 % Vendor C 10 % 11 %
Schedule Of Foreign Currency Exchange Rate	The following table summarizes the exchange rates used: Year Ended June 30, 2019 2018 Period end Euro : US Dollar exchange rate 1.14 1.17 Average period Euro : US Dollar exchange rate 1.14 1.19 Period end Mexican Peso : US Dollar exchange rate 0.05 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Jun. 30, 2019
Property and Equipment
Schedule of Property, Plant and Equipment	Property and equipment consists of the following as of June 30, 2019 and 2018: June 30, June 30, 2019 2018 Computer equipment $ 504,652 $ 489,540 Software 282,080 279,817 Furniture and fixtures 39,884 39,609 Total 826,616 808,966 Less accumulated depreciation (789,788) (749,923) Net, Property and equipment $ 36,828 $ 59,043

Lease Obligations (Tables)

Lease Obligations (Tables)	12 Months Ended
	Jun. 30, 2019
Lease Obligations
Schedule of future minimum lease payments under leases	Future minimum lease payments under the leases are as follows: Years Ending June 30, Amount 2020 $ 135,035 2021 80,356 Total payments 215,391 Less: Amount representing interest 6,878 Present value of net minimum lease payments 208,513 Less: Current portion 129,187 Non-current portion $ 79,326

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Jun. 30, 2019
Stockholders' Equity
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Weighted Weighted Weighted Average Average Average Exercise Exercise Exercise Shares Price Shares Price Shares Price Outstanding at July 1, 2017 3,130,310 1.15 2,994,851 1.15 135,459 1.07 Granted 807,000 1.31 750,000 1.30 57,000 1.44 Options vesting — — 74,333 1.07 (74,333) 1.07 Exercised (462,766) 1.19 (462,766) 1.19 — — Forfeited/Cancelled (482,709) 1.31 (471,042) 1.32 (11,667) 1.07 Outstanding at June 30, 2018 2,991,835 1.16 2,885,376 1.15 106,459 1.27 Granted 717,000 2.22 250,000 2.40 467,000 2.12 Options vesting — — 105,042 1.49 (105,042) 1.49 Exercised (396,500) 1.19 (396,500) 1.19 — — Forfeited/Cancelled (25,000) 1.05 (16,667) 1.05 (8,333) 1.05 Outstanding at June 30, 2019 3,287,335 $ 1.38 2,827,251 $ 1.27 460,084 $ 2.09
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table presents the assumptions used to estimate the fair values based upon a Black-Scholes option pricing model of the stock options granted during the years ended June 30, 2019 and 2018. Years Ended June 30, 2019 2018 Expected dividend yield — % — % Risk-free interest rate 2.82% - 3.00 % 1.45% - 2.88 % Expected life (in years) 5 - 6 2.6 - 6.0 Expected volatility 68% - 69 % 68% - 76 %
Schedule of Share-based Compensation, by Exercise Price Range	Additional information regarding stock options outstanding and exercisable as of June 30, 2019 is as follows: Option Remaining Exercise Options Contractual Options Price Outstanding Life (in years) Exercisable $ 0.59 8,150 3.00 8,150 0.60 5,000 3.00 5,000 0.65 6,150 3.00 6,150 0.70 225,000 6.44 225,000 0.77 59,500 4.26 59,500 0.80 16,000 6.15 16,000 0.90 25,667 4.81 25,667 0.97 6,000 3.00 6,000 1.00 28,249 4.43 28,249 1.02 227,000 1.43 227,000 1.05 422,529 7.11 419,446 1.07 53,898 3.30 53,898 1.09 151,165 6.44 151,165 1.10 105,000 6.01 105,000 1.14 3,674 3.00 3,674 1.15 209,400 5.12 209,400 1.20 352,414 8.08 343,247 1.25 32,000 3.63 32,000 1.30 243,000 2.68 243,000 1.50 195,000 3.38 195,000 1.59 35,000 8.87 14,583 1.75 1,067 3.00 1,067 1.80 134,050 3.89 134,050 1.85 24,000 3.59 24,000 1.95 295,000 9.02 39,583 1.97 1,422 3.00 1,422 2.40 9.38 2.50 9.89 — Total
Schedule of Other Share-based Compensation, Activity	The following table summarizes warrant activity: Weighted Average Number of Exercise Warrants Price Outstanding, June 30, 2017 1,985,000 $ 1.25 Granted — — Exercised — — Expired/Cancelled — — Outstanding, June 30, 2018 1,985,000 1.25 Granted — — Exercised (100,000) 1.22 Expired/Cancelled — — Outstanding, June 30, 2019 1,885,000 $ 1.25 Exercisable, June 30, 2018 1,985,000 $ 1.25 Exercisable, June 30, 2019 1,885,000 $ 1.25
Schedule of Stockholders' Equity Note, Warrants or Rights	Additional information regarding warrants outstanding and exercisable as of June 30, 2019 is as follows: Remaining Warrant Warrants Contractual Warrants Exercise Price Outstanding Life (in years) Exercisable $ 1.19 100,000 2.48 100,000 1.25 1,835,000 1.97 1,835,000 Total 1,885,000 1,885,000
Schedule of Nonvested Restricted Stock Units Activity	The following table summarizes restricted common stock activity: Weighted Average Number of Grant Date Shares Fair Value Fair Value Non-vested, June 30, 2017 513,194 $ 412,938 $ 0.92 Granted 423,107 467,952 1.11 Vested (305,358) (332,527) 0.91 Forfeited (214,324) (188,203) 1.00 Non-vested, June 30, 2018 416,619 360,160 1.08 Granted 170,245 355,417 2.09 Vested (275,329) (303,194) 1.05 Forfeited — — — Non-vested, June 30, 2019 311,535 $ 412,383 $ 1.66
Schedule of Repurchase Agreements	The following table summarizes repurchases of our common stock on a monthly basis: Total Number of Shares Approximate Dollar Value Total Number Average Purchased as Part of of Shares that May Yet Be of Shares Price Paid Publicly Announced Purchased Under the Period Purchased 1 per Share Plans or Programs Plans or Programs September 2017 34,800 $ 1.14 — — December 2017 52,300 $ 1.21 — — March 2018 19,750 $ 1.29 — — June 2018 14,050 $ 1.73 — — Year ended June 30, 2018 120,900 $ 1.26 — — September 2018 34,200 $ 2.20 — — December 2018 15,800 $ 2.41 — — March 2019 20,500 $ 2.24 — $ 254,080 June 2019 17,750 $ 2.30 — $ 213,255 Year ended June 30, 2019 88,250 $ 2.27 — $ 213,255 1 Consists of shares of common stock purchased from employees to satisfy tax obligations in connection with the vesting of stock incentive awards.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 30, 2019
Income Taxes
Schedule of Components of Income Tax Expense (Benefit)	The provision for income taxes consists of the following for the years ended June 30, 2019 and 2018: Years Ended June 30, 2019 2018 Current Federal $ — $ — State 2,088 2,629 Foreign (Mexico) 24,952 37,150 Deferred Federal — — Foreign — — State — — Provision for income tax expense $ 27,040 $ 39,779
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation of the effective income tax rate to the federal statutory rate is as follows: Years Ended June 30, 2019 2018 Federal income tax rate 21.0 % 34.0 % State tax, net of federal benefit (5.0) % (5.0) % Permanent differences 4.8 % 2.8 % Change in valuation allowance (23.6) % (34.1) % Effective income tax rate (2.8) % (2.4) %
Schedule of Deferred Tax Assets and Liabilities	Significant components of the Company’s deferred tax assets and liabilities at June 30, 2019 and 2018 are as follows: June 30, June 30, 2019 2018 Deferred tax assets: Federal net operating loss carryforward $ 2,587,483 $ 2,585,767 State net operating loss carryforward 387,834 387,112 Intangibles amortization 156,196 156,196 Stock based compensation 1,351,437 1,177,731 Other 176,403 165,901 Total deferred tax assets 4,659,353 4,472,707 Deferred tax liability: Fixed asset depreciation 46,299 40,248 Net deferred tax assets 4,705,652 4,512,955 Less valuation allowance (4,705,652) (4,512,955) $ — $ —

Organization, Nature of Busin_2

Organization, Nature of Business and Basis of Presentation (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2017
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Proceeds from Sale of Intangible Assets		$ 450,000
Reprints and ePrints business line [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Proceeds from Sale of Intangible Assets		$ 450,000
Earn-out Income Percentage On Sale Of Intangible Assets	45.00%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Content costs (Details)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Vendor A [Member]
Concentration Risk, Percentage	17.00%	15.00%
Vendor B [Member]
Concentration Risk, Percentage	12.00%	12.00%
Vendor C [Member]
Concentration Risk, Percentage	10.00%	11.00%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Exchange rates (Details)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Euro to US Dollar [Member]
Average Period Foreign Currency Exchange Rate Translation	1.14	1.19
Period end exchange rate	1.14	1.17
Mexican Peso to US Dollar [Member]
Average Period Foreign Currency Exchange Rate Translation	0.05	0.05
Period end exchange rate	0.05	0.05

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash, FDIC Insured Amount	$ 250,000
Foreign Currency Transaction Gain (Loss), before Tax	(24,500)	$ 8,020
Allowance for Doubtful Accounts Receivable	$ 100,175	$ 115,040
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	311,535	416,619
Sales Revenue, Net [Member]
Concentration Risk, Percentage	10.00%	10.00%
Accounts Receivable [Member]
Concentration Risk, Percentage	10.00%	10.00%
Minimum [Member]
Property, Plant and Equipment, Useful Life	3 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	7 years
Europe Financial Institutions [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	63,933	109,585
Deposits	$ 63,933	$ 109,585
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,287,335	2,991,835
Employee Stock Option [Member] | Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,885,000	1,985,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Total	$ 826,616	$ 808,966
Less accumulated depreciation	(789,788)	(749,923)
Net, Property and equipment	36,828	59,043
Computer Equipment [Member]
Total	504,652	489,540
Computer Software, Intangible Asset [Member]
Total	282,080	279,817
Furniture and Fixtures [Member]
Total	$ 39,884	$ 39,609

Property and Equipment - Additi

Property and Equipment - Additional Information (Details) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Property and Equipment
Depreciation	$ 38,816	$ 53,075

Line of Credit - Additional Inf

Line of Credit - Additional Information (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 23, 2010	Jun. 30, 2019
Line of Credit Facility, Interest Rate Description		the prime rate plus 5.25%
Line of Credit Facility, Remaining Borrowing Capacity		$ 2,215,000
Line of Credit Facility, Interest Rate at Period End		6.75%
Debt Instrument, Covenant Description		Financial covenants include maintaining an adjusted quick ratio of unrestricted cash and net accounts receivable, divided by current liabilities plus debt less deferred revenue of at least 1.15 to 1.0, and maintaining tangible net worth of $1,500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2017, plus 50% of the dollar value of equity issuances after October 1, 2017 and the principal amount of subordinated debt.
Minimum [Member]
Debt Instrument, Covenant Compliance		1.0
Maximum [Member]
Debt Instrument, Covenant Compliance		1.3
Silicon Valley Bank [Member]
Line of Credit Facility, Amount Outstanding	$ 2,500,000
Line Of Credit Facility Expiration Date 1		Dec. 31, 2019
Debt Instrument, Basis Spread on Variable Rate		2.25%
Percentage Of Eligible Accounts Receivable On Line Of Credit	80.00%

Lease Obligations (Details)

Lease Obligations (Details) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Lease Obligations
2020	$ 135,035
2021	80,356
Total payments	215,391
Less: Amount representing interest	6,878
Present value of net minimum lease payments	208,513	$ 328,299
Less: Current portion	129,187	119,786
Non-current portion	$ 79,326	$ 208,513

Lease Obligations - Additional

Lease Obligations - Additional Information (Details) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 30, 2016	Jun. 30, 2019	Jun. 30, 2018
Operating Lease Liabilities, Fair Value		$ 463,000
Operating Lease Discount Rate		3.75%
Operating Leases, Rent Expense		$ 144,963	$ 142,742
Amortization of Leased Asset		115,079	110,593
Operating Lease, Payments		119,786
Operating Lease, Liability		208,513	328,299
Other Assets, Noncurrent		$ 192,245	$ 307,324
Minimum [Member]
Operating Leases, Rent Expense, Minimum Rentals	$ 10,350
Maximum [Member]
Operating Leases, Rent Expense, Minimum Rentals	$ 11,475

Stockholders' Equity - Vested a

Stockholders' Equity - Vested and unvested stock option (Details) - $ / shares	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Outstanding beginning balance Shares	2,991,835	3,130,310
Granted Shares	717,000	807,000
Options vesting Shares	0	0
Exercised Shares	(396,500)	(462,766)
Forfeited/Cancelled Shares	(25,000)	(482,709)
Outstanding ending balance Shares	3,287,335	2,991,835
Outstanding beginning balance Weighted Average Exercise Price	$ 1.16	$ 1.15
Granted Weighted Average Exercise Price	2.22	1.31
Options vesting Weighted Average Exercise Price	0	0
Exercised Weighted Average Exercise Price	1.19	1.19
Forfeited/Cancelled Weighted Average Exercise Price	1.05	1.31
Outstanding ending balance Weighted Average Exercise Price	$ 1.38	$ 1.16
Vested Options [Member]
Outstanding beginning balance Shares	2,885,376	2,994,851
Granted Shares	250,000	750,000
Options vesting Shares	105,042	74,333
Exercised Shares	(396,500)	(462,766)
Forfeited/Cancelled Shares	(16,667)	(471,042)
Outstanding ending balance Shares	2,827,251	2,885,376
Outstanding beginning balance Weighted Average Exercise Price	$ 1.15	$ 1.15
Granted Weighted Average Exercise Price	2.40	1.30
Options vesting Weighted Average Exercise Price	1.49	1.07
Exercised Weighted Average Exercise Price	1.19	1.19
Forfeited/Cancelled Weighted Average Exercise Price	1.05	1.32
Outstanding ending balance Weighted Average Exercise Price	$ 1.27	$ 1.15
Unvested Options [Member]
Outstanding beginning balance Shares	106,459	135,459
Granted Shares	467,000	57,000
Options vesting Shares	(105,042)	(74,333)
Exercised Shares	0	0
Forfeited/Cancelled Shares	(8,333)	(11,667)
Outstanding ending balance Shares	460,084	106,459
Outstanding beginning balance Weighted Average Exercise Price	$ 1.27	$ 1.07
Granted Weighted Average Exercise Price	2.12	1.44
Options vesting Weighted Average Exercise Price	1.49	1.07
Exercised Weighted Average Exercise Price	0	0
Forfeited/Cancelled Weighted Average Exercise Price	1.05	1.07
Outstanding ending balance Weighted Average Exercise Price	$ 2.09	$ 1.27

Stockholders' Equity - Estimate

Stockholders' Equity - Estimate the fair values (Details)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Maximum [Member]
Risk-free interest rate	3.00%	2.88%
Expected life (in years)	6 years	6 years
Expected volatility	69.00%	76.00%
Minimum [Member]
Risk-free interest rate	2.82%	1.45%
Expected life (in years)	5 years	2 years 7 months 6 days
Expected volatility	68.00%	68.00%

Stockholders' Equity - Stock op

Stockholders' Equity - Stock options outstanding and exercisable (Details)	12 Months Ended
	Jun. 30, 2019$ / sharesshares
Options Outstanding	3,287,335
Options Exercisable	2,827,251
Range One [Member]
Option Exercise Price | $ / shares	$ 0.59
Options Outstanding	8,150
Remaining Contractual Life (in years)	3 years
Options Exercisable	8,150
Range Two [Member]
Option Exercise Price | $ / shares	$ 0.60
Options Outstanding	5,000
Remaining Contractual Life (in years)	3 years
Options Exercisable	5,000
Range Three [Member]
Option Exercise Price | $ / shares	$ 0.65
Options Outstanding	6,150
Remaining Contractual Life (in years)	3 years
Options Exercisable	6,150
Range Four [Member]
Option Exercise Price | $ / shares	$ 0.70
Options Outstanding	225,000
Remaining Contractual Life (in years)	6 years 5 months 9 days
Options Exercisable	225,000
Range Five [Member]
Option Exercise Price | $ / shares	$ 0.77
Options Outstanding	59,500
Remaining Contractual Life (in years)	4 years 3 months 4 days
Options Exercisable	59,500
Range Six [Member]
Option Exercise Price | $ / shares	$ 0.80
Options Outstanding	16,000
Remaining Contractual Life (in years)	6 years 1 month 24 days
Options Exercisable	16,000
Range Seven [Member]
Option Exercise Price | $ / shares	$ 0.90
Options Outstanding	25,667
Remaining Contractual Life (in years)	4 years 9 months 22 days
Options Exercisable	25,667
Range Eight [Member]
Option Exercise Price | $ / shares	$ 0.97
Options Outstanding	6,000
Remaining Contractual Life (in years)	3 years
Options Exercisable	6,000
Range Nine [Member]
Option Exercise Price | $ / shares	$ 1
Options Outstanding	28,249
Remaining Contractual Life (in years)	4 years 5 months 5 days
Options Exercisable	28,249
Range Ten [Member]
Option Exercise Price | $ / shares	$ 1.02
Options Outstanding	227,000
Remaining Contractual Life (in years)	1 year 5 months 5 days
Options Exercisable	227,000
Range Eleven [Member]
Option Exercise Price | $ / shares	$ 1.05
Options Outstanding	422,529
Remaining Contractual Life (in years)	7 years 1 month 10 days
Options Exercisable	419,446
Range Twelve [Member]
Option Exercise Price | $ / shares	$ 1.07
Options Outstanding	53,898
Remaining Contractual Life (in years)	3 years 3 months 18 days
Options Exercisable	53,898
Range Thirteen [Member]
Option Exercise Price | $ / shares	$ 1.09
Options Outstanding	151,165
Remaining Contractual Life (in years)	6 years 5 months 9 days
Options Exercisable	151,165
Range Fourteen [Member]
Option Exercise Price | $ / shares	$ 1.10
Options Outstanding	105,000
Remaining Contractual Life (in years)	6 years 4 days
Options Exercisable	105,000
Range Fifteen [Member]
Option Exercise Price | $ / shares	$ 1.14
Options Outstanding	3,674
Remaining Contractual Life (in years)	3 years
Options Exercisable	3,674
Range Sixteen [Member]
Option Exercise Price | $ / shares	$ 1.15
Options Outstanding	209,400
Remaining Contractual Life (in years)	5 years 1 month 13 days
Options Exercisable	209,400
Range Seventeen [Member]
Option Exercise Price | $ / shares	$ 1.20
Options Outstanding	352,414
Remaining Contractual Life (in years)	8 years 29 days
Options Exercisable	343,247
Range Eighteen [Member]
Option Exercise Price | $ / shares	$ 1.25
Options Outstanding	32,000
Remaining Contractual Life (in years)	3 years 7 months 17 days
Options Exercisable	32,000
Range Nineteen [Member]
Option Exercise Price | $ / shares	$ 1.30
Options Outstanding	243,000
Remaining Contractual Life (in years)	2 years 8 months 5 days
Options Exercisable	243,000
Range Twenty [Member]
Option Exercise Price | $ / shares	$ 1.50
Options Outstanding	195,000
Remaining Contractual Life (in years)	3 years 4 months 17 days
Options Exercisable	195,000
Range Twenty One [Member]
Option Exercise Price | $ / shares	$ 1.59
Options Outstanding	35,000
Remaining Contractual Life (in years)	8 years 10 months 13 days
Options Exercisable	14,583
Range Twenty Two [Member]
Option Exercise Price | $ / shares	$ 1.75
Options Outstanding	1,067
Remaining Contractual Life (in years)	3 years
Options Exercisable	1,067
Range Twenty Three [Member]
Option Exercise Price | $ / shares	$ 1.80
Options Outstanding	134,050
Remaining Contractual Life (in years)	3 years 10 months 21 days
Options Exercisable	134,050
Range Twenty Four [Member]
Option Exercise Price | $ / shares	$ 1.85
Options Outstanding	24,000
Remaining Contractual Life (in years)	3 years 7 months 2 days
Options Exercisable	24,000
Range Twenty Five [Member]
Option Exercise Price | $ / shares	$ 1.95
Options Outstanding	295,000
Remaining Contractual Life (in years)	9 years 7 days
Options Exercisable	39,583
Range Twenty Six [Member]
Option Exercise Price | $ / shares	$ 1.97
Options Outstanding	1,422
Remaining Contractual Life (in years)	3 years
Options Exercisable	1,422
Range Twenty Seven [Member]
Option Exercise Price | $ / shares	$ 2.40
Options Outstanding	402,000
Remaining Contractual Life (in years)	9 years 4 months 17 days
Options Exercisable	250,000
Range Twenty Eight [Member]
Option Exercise Price | $ / shares	$ 2.50
Options Outstanding	20,000
Remaining Contractual Life (in years)	9 years 10 months 21 days
Options Exercisable	0

Stockholders' Equity - Warrant

Stockholders' Equity - Warrant activity (Details) - $ / shares	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Non-vested, Ending balance	1,885,000
Exercisable	1,885,000
Warrant [Member]
Non-vested, Beginning balance	1,985,000	1,985,000
Granted	0	0
Exercised	(100,000)	0
Expired/Cancelled	0	0
Non-vested, Ending balance	1,885,000	1,985,000
Exercisable	1,885,000	1,985,000
Outstanding, Beginning balance Weighted Average Exercise Price	$ 1.25	$ 1.25
Granted Weighted Average Exercise Price	0	0
Exercised Weighted Average Exercise Price	1.22	0
Expired/Cancelled Weighted Average Expired Price	0	0
Outstanding, Ending balance Weighted Average Exercise Price	1.25	1.25
Exercisable, Weighted Average Exercise Price	$ 1.25	$ 1.25

Stockholders' Equity - Warrants

Stockholders' Equity - Warrants outstanding and exercisable (Details)	12 Months Ended
	Jun. 30, 2019$ / sharesshares
Warrants Outstanding	1,885,000
Warrants Exercisable	1,885,000
Range One [Member]
Warrant Exercise Price | $ / shares	$ 1.19
Warrants Outstanding	100,000
Warrants Outstanding Remaining Contractual Life (in years)	2 years 5 months 23 days
Warrants Exercisable	100,000
Range Two [Member]
Warrant Exercise Price | $ / shares	$ 1.25
Warrants Outstanding	1,835,000
Warrants Outstanding Remaining Contractual Life (in years)	1 year 11 months 19 days
Warrants Exercisable	1,835,000

Stockholders' Equity - Restrict

Stockholders' Equity - Restricted common stock activity (Details) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Non-vested, Ending balance	1,885,000
Restricted Stock [Member]
Non-vested, Beginning balance	416,619	513,194
Granted Number of shares	170,245	423,107
Vested, Number of shares	(275,329)	(305,358)
Forfeited, Number of shares	0	(214,324)
Non-vested, Ending balance	311,535	416,619
Non-vested, Beginning balance	$ 360,160	$ 412,938
Granted, Fair Value	355,417	467,952
Vested, Fair Value	(303,194)	(332,527)
Forfeited, Fair Value	0	(188,203)
Non-vested, Ending balance	$ 412,383	$ 360,160
Non-vested, Beginning Balance Weighted Average Grant Date Fair Value	$ 1.08	$ 0.92
Granted Weighted Average Grant Date Fair Value	2.09	1.11
Vested Weighted Average Grant Date Fair Value	1.05	0.91
Forfeited Weighted Average Grant Date Fair Value	0	1
Non-vested, Ending Balance Weighted Average Grant Date Fair Value	$ 1.66	$ 1.08

Stockholders' Equity - Repurcha

Stockholders' Equity - Repurchases of our common stock (Details) - USD ($)	Feb. 08, 2018	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2019	Jun. 30, 2018
Stock Repurchased During Period, Shares		17,750	20,500	15,800	34,200	14,050	19,750	52,300	34,800	88,250	120,900
Treasury Stock Acquired, Average Cost Per Share	$ 3	$ 2.30	$ 2.24	$ 2.41	$ 2.20	$ 1.73	$ 1.29	$ 1.21	$ 1.14	$ 2.27	$ 1.26
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 213,255	$ 254,080	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 213,255	$ 0
Publicly Announced Plans Or Programs [Member]
Stock Repurchased During Period, Shares		0	0	0	0	0	0	0	0	0	0

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($)	Nov. 13, 2018	Feb. 08, 2018	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Nov. 21, 2017	Nov. 10, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			537,246								537,246			1,874,513
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term											6 years 1 month 17 days	6 years 4 months 21 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value			$ 4,588,211								$ 4,588,211
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value			4,268,743								4,268,743
Stock or Unit Option Plan Expense											0	$ 6,233
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options			$ 425,901				$ 73,353				425,901	73,353
Stock Issued During Period, Value, Restricted Stock Award, Gross											$ 303,194	$ 332,529
Stock Repurchase Program, Authorized Amount	$ 300,000	$ 300,000
Stock Repurchased During Period, Shares			17,750	20,500	15,800	34,200	14,050	19,750	52,300	34,800	88,250	120,900
Stock Repurchased During Period, Value											$ 200,023	$ 152,739
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross											717,000	807,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value											$ 523,978	$ 451,475
Proceeds from Stock Options Exercised											$ 100,000	$ 0
Stock Repurchased Average Price Per Share											$ 2.27	$ 1.26
Intrinsic value of warrant			$ 2,887,050								$ 2,887,050
Treasury Stock Acquired, Average Cost Per Share		$ 3	$ 2.30	$ 2.24	$ 2.41	$ 2.20	$ 1.73	$ 1.29	$ 1.21	$ 1.14	$ 2.27	$ 1.26
Stock Repurchase Program, Remaining Authorized Repurchase Amount			$ 213,255	$ 254,080	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 213,255	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number			1,885,000								1,885,000
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)												100,000
Common Stock [Member]
Stock Repurchased During Period, Shares											88,250	120,900
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross											92,954	45,971
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)												462,766
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)											221,500
Stock Issued During Period, Shares, Conversion of Convertible Securities												39,000
Cash and Common Stock [Member ]
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)											175,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period											145,000
Employees And Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross											717,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value											$ 881,860	$ 455,040
Restricted Stock [Member]
Stock or Unit Option Plan Expense													$ 1,150,136
Stock Issued During Period, Shares, Restricted Stock Award, Gross											170,245
Stock Issued During Period, Value, Restricted Stock Award, Gross											$ 355,417		1,563,074
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value													$ 1,573,197
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options			$ 412,383								$ 412,383
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period											0	214,324
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Fair Value											$ 0	$ (188,203)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number			311,535				416,619				311,535	416,619	513,194
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Fair Value			$ 412,383				$ 360,160				$ 412,383	$ 360,160	$ 412,938
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Fair Value											$ 303,194	$ 332,527
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period											170,245	423,107
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants In Period, Fair Value											$ 355,417	$ 467,952
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant															5,000,000
Minimum [Member] | Restricted Stock [Member]
Sale of Stock, Price Per Share			$ 1.99				$ 1.02				$ 1.99	$ 1.02
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant															7,000,000
Treasury Stock Acquired, Average Cost Per Share	$ 3
Maximum [Member] | Restricted Stock [Member]
Sale of Stock, Price Per Share			$ 2.50				$ 1.59				$ 2.50	$ 1.59

Income Taxes - Provision for in

Income Taxes - Provision for income taxes (Details) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Current
Federal	$ 0	$ 0
State	2,088	2,629
Foreign (Mexico)	24,952	37,150
Deferred
Federal	0	0
Foreign	0	0
State	0	0
Provision for income tax expense	$ 27,040	$ 39,779

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of the effective income tax rate (Details) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Income Taxes
Federal income tax rate	$ 21	$ 34
State tax, net of federal benefit	(5.00%)	(5.00%)
Permanent differences	4.80%	2.80%
Change in valuation allowance	(23.60%)	(34.10%)
Effective income tax rate	(2.80%)	(2.40%)

Income Taxes - Significant comp

Income Taxes - Significant components of the Company's deferred tax assets and liabilities (Details) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Deferred Tax Assets, Gross
Federal net operating loss carryforward	$ 2,587,483	$ 2,585,767
State net operating loss carryforward	387,834	387,112
Intangibles amortization	156,196	156,196
Stock based compensation	1,351,437	1,177,731
Other	176,403	165,901
Total deferred tax assets	4,659,353	4,472,707
Deferred Tax Liabilities, Gross
Fixed asset depreciation	46,299	40,248
Net deferred tax assets	4,705,652	4,512,955
Less valuation allowance	(4,705,652)	(4,512,955)
Deferred Tax Assets, Net	$ 0	$ 0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details Textual) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Income Tax Expense (Benefit)	$ 27,040	$ 39,779
Current State and Local Tax Expense (Benefit)	2,088	2,629
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	192,695
Current Foreign Tax Expense (Benefit)	24,952	37,150
Domestic Tax Authority [Member]
Operating Loss Carryforwards	12,735,000	11,750,000
State and Local Jurisdiction [Member]
Operating Loss Carryforwards	$ 6,445,000	$ 6,500,000
Tax Credit Carryforward, Expiration Date	Dec. 31, 2038
Federal [Member]
Tax Credit Carryforward, Expiration Date	Dec. 31, 2033

Gain from Sale of Discontinue_2

Gain from Sale of Discontinued Operations (Reprints and ePrints business line) (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017
Proceeds from Sale of Intangible Assets				$ 450,000
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax		$ 214,737	$ 256,995
Reprints and ePrints business line [Member]
Proceeds from Sale of Intangible Assets				$ 450,000
Earn-out Income Percentage On Sale Of Intangible Assets	45.00%
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax		$ 214,737	$ 256,995

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Aug. 02, 2019	Aug. 01, 2019	Jun. 30, 2019	Jun. 30, 2018
Stock Issued During Period, Value, Restricted Stock Award, Gross			$ 303,194	$ 332,529
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			717,000	807,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value			$ 523,978	$ 451,475
Subsequent Event [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		70,000
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 192,500
Sale of Stock, Price Per Share		$ 2.75
Stock Issued During Period Share Warrants Exercised	24,307
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised	40,000